Latanostill

Latanoprost, the active ingredient in Latanostill, is a Prostaglandin F2α analog presented as eye drops for ocular use. It lowers intra‑ocular pressure and is employed in the management of open‑angle glaucoma and ocular hypertension in adult patients who require long‑term IOP control.

GNH USA supplies Latanostill as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Clients benefit from comprehensive regulatory support and timely delivery across multiple regions.

Latanostill (latanoprost) reduces intra‑ocular pressure by enhancing aqueous humor outflow, and is indicated for the following ocular conditions:

Open‑angle glaucoma: lowers intra‑ocular pressure to slow disease progression. Ocular hypertension: reduces elevated eye pressure to prevent development of glaucoma. Pseudoexfoliative glaucoma: decreases intra‑ocular pressure in this secondary open‑angle glaucoma subtype.

Latanostill may cause ocular and systemic adverse reactions; the most frequently reported are listed below.

Common Side Effects: - Eye redness: mild conjunctival hyperemia. - Eye itching: transient pruritus. - Increased iris pigmentation: gradual darkening of the iris color. - Eyelash changes: growth and darkening of eyelashes.

Serious or Rare Side Effects: - Severe eye inflammation: uveitis or iritis requiring medical attention. - Allergic reaction: swelling, rash, or severe irritation of the eye. - Vision loss: sudden decrease in visual acuity.

Before using Latanostill, consider the following precautions to ensure safe and effective therapy.

Monitor intra‑ocular pressure: regular eye‑pressure checks are required. Avoid contact lenses: do not wear soft lenses for at least 15 minutes after instillation. Inform surgeon: disclose use before any ocular surgery. Do not use in active eye infection: postpone treatment until resolved. Discontinue if severe side effects occur: seek ophthalmologic evaluation. Store at room temperature: keep bottle tightly closed, protect from light, and store in original container.

Latanostill can interact with other ocular or systemic agents; the following interactions are noteworthy.

Major Interactions (Avoid): - Concurrent use with other prostaglandin analogs: may increase risk of ocular side effects. - Use with ocular corticosteroids: can reduce steroid efficacy and increase inflammation risk.

Moderate Interactions (Monitor Closely): - Combination with beta‑blocker eye drops: additive intra‑ocular pressure lowering effect, monitor pressure. - Use with carbonic anhydrase inhibitor eye drops: may enhance pressure reduction, adjust dosing if needed. - Systemic NSAIDs: may modestly affect prostaglandin pathways, observe for changes.